Patients Stopping Slimming Jabs Put On Weight at a Quadrupled Rate Than People Using Diet and Exercise

New research reveals that patients who stop using popular slimming jabs like semaglutide or tirzepatide may regain shed pounds much more quickly than those who stop traditional lifestyle plans.

Research printed in a leading medical journal points out that while obese individuals often shed a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing these medications must be cognizant of the danger of quick weight regain when the medication ends," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to original weight in about a year and a half.

Analyzing Approaches

The study, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of these new drugs with other pills.

Researchers note that people who lose weight through dieting typically experience a less rapid weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Rapid Rebound

Doctors suggest the way of the jabs explains the amplified rebound.

The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness.

"Sustained high doses of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication leads to hunger is no longer kept in check, making overeating much more probable."

A Lifelong Condition?

Medical guidelines suggest the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.

A number of clinicians contend that, considering the likelihood of weight regain, the treatment is often life-long.

This perspective is echoed by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," similar to managing conditions like diabetes.

User Accounts

People who have discontinued the jabs explain a sudden return of appetite.

"I experienced a trigger activating and you're instantly ravenous," recalled one woman.

This difficulty is compounded if patients have not adopted permanent lifestyle or habit changes during therapy.

Widespread Interest

Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with demand being substantial.

• Use is higher among women than males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion obtain the drugs through private healthcare rather than public health services.

Finally, experts stress that while the jabs are effective agents for weight loss, they are not a permanent fix and maintained weight loss hinges on integrated behavioural management.